JAC Advance Access published online on October 21, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki394
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland
* To whom correspondence should be addressed.
Correspondence
Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus
C. De Gascun, E-mail: cfbdeg{at}hotmail.com
This article has no Abstract.
Keywords:
S. aureus; cytokines; exotoxins; antimicrobial activity.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Thallinger, C. Buerger, N. Plock, S. Kljucar, S. Wuenscher, R. Sauermann, C. Kloft, and C. Joukhadar Effect of severity of sepsis on tissue concentrations of linezolid J. Antimicrob. Chemother., January 1, 2008; 61(1): 173 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. De Beeck, N. Dhif, J. Philipp, and D. De Bels Comment on: Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus J. Antimicrob. Chemother., March 1, 2006; 57(3): 577 - 577. [Full Text] [PDF] |
||||
